Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Patient Focus Groups 2020

Data to Support Drug Product Communications

Invitation

Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Patient Focus Groups 2020

OMB: 0910-0695

Document [docx]
Download: docx | pdf

OMB Control No. 0910-0695

Expiration Date: 2/28/2021


Biosimilars Patient Study

Focus Group Invitation



Hello [NAME],

Survey Healthcare Globus is hosting online focus group discussions to get feedback on health-related materials.

(No honorarium for the qualifying questions. Honorarium credited to account upon completion of the focus group and close of project.)

Topic Health-related materials [JOB NUMBER]

Length 5-minute qualifying screener + 90-minute online focus group

Honorarium – $75

Start Survey Here




Need help? | Reference Code: [IDENTIFIER]



Pat Stuart
Panel Administrator

This invitation is only for [NAME] and honorarium will only be paid to [NAME].  If you are receiving this message in error, please contact Survey Healthcare Globus for correction. By participating in this market research you agree to our notice and privacy policy.
Market Research Anonymity Disclosure: We are an independent Market Research company and not affiliated with any Pharmaceutical Company or Medical Device Manufacturer.  Your participation is completely confidential, and your personal information will not be disclosed without your express consent.
*The honoraria offered for this project will be credited to your portal upon successful completion. For more information on our honoraria process please click here.

If you only want to be removed from this study, please click here.
If you no longer want to receive survey invites and to be removed from the community, please click here.




File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorRupert, Douglas
File Modified0000-00-00
File Created2021-01-14

© 2024 OMB.report | Privacy Policy